Spinal cord compression: prognosis and implications for treatment fractionation

Area of Science:

• Oncology
• Radiotherapy
• Neurosurgery

Background:

• Metastatic extradural spinal cord compression (ESCC) is a common complication of advanced cancer.
• ESCC can lead to significant morbidity, including motor deficits and sphincter dysfunction.
• Optimal radiotherapy fractionation for ESCC remains a subject of clinical investigation.

Purpose of the Study:

• To evaluate the clinical outcomes of patients with metastatic extradural spinal cord compression treated with radiotherapy.
• To compare the efficacy of low-fraction versus protracted radiotherapy regimens in managing ESCC.
• To determine prognostic factors influencing survival and functional recovery in ESCC.

Main Methods:

• Retrospective review of 158 cases of metastatic ESCC.
• Data collected from three radiotherapy departments.
• Analysis of survival time, motor function recovery, and sphincter function recovery.

Main Results:

• Median survival time for patients with ESCC was less than 3 months.
• Recovery of motor and sphincter function was uncommon following treatment.
• Low-fraction (2-5 fractions) radiotherapy regimens demonstrated similar clinical outcomes to more protracted regimens.

Conclusions:

• Metastatic ESCC carries a poor prognosis with limited survival and functional recovery.
• Fractionation schedule in radiotherapy for ESCC may not significantly impact clinical outcomes.
• Further research into novel therapeutic strategies is warranted for improving outcomes in ESCC.